Hospital
West Ascension Parish Hospital Service District
West Ascension Parish Hospital Service District was paid $3.19M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99283, emergency room visit (moderate) — 64% of everything it billed.
33Billing provider infoWEST ASCENSION PARISH HOSPITAL SERVICE DISTRICT
DONALDSONVILLE, LA 70346
DONALDSONVILLE, LA 70346
33aNPI1306849617assigned 05/31/2005
33bProvider typeCritical Access Hospital
28Total paid$3.19M
24GClaims49,722
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Louisiana
Rank by total paid#21 of 40
Median peer was paid$3.19M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,822 | $395K | |
| 2019 | 7,634 | $467K | |
| 2020 | 4,013 | $289K | |
| 2021 | 7,202 | $530K | |
| 2022 | 7,518 | $573K | |
| 2023 | 9,328 | $510K | |
| 2024incomplete | 7,205 | $427K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 64% | 18,228 | 15,619 | $2.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.4% | 1,698 | 1,501 | $267K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.7% | 2,281 | 1,923 | $182K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.8% | 2,128 | 1,746 | $153K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.3% | 2,127 | 1,922 | $136K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.8% | 441 | 178 | $122K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.9% | 738 | 477 | $61K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 1,099 | 824 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,048 | 842 | $30K |
| 80053 | Comprehensive metabolic panel | <1% | 3,247 | 2,644 | $24K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 590 | 479 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,787 | 3,062 | $20K |
37 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 240 | $19K |
| 81001 | <1% | 5,720 | $11K | |
| 81025 | <1% | 1,294 | $9K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 17 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 64 | $5K |
| 87088 | <1% | 666 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 614 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,960 | $4K |
| 93225 | <1% | 256 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 96 | $3K |
| 99285 | Emergency room visit (most serious) | <1% | 27 | $3K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 53 | $3K |
| 80061 | Lipid panel | <1% | 215 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 57 | $2K |
| 93041 | <1% | 44 | $1K | |
| 80050 | General health panel | <1% | 38 | $1K |
| 87634 | <1% | 17 | $982.80 | |
| 87077 | <1% | 88 | $890.74 | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $855.00 |
| 87070 | <1% | 115 | $814.70 | |
| 87186 | <1% | 100 | $622.25 | |
| 80377 | <1% | 44 | $527.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 62 | $416.99 |
| 82043 | <1% | 87 | $395.02 | |
| 82570 | <1% | 87 | $366.58 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 50 | $310.59 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 17 | $266.40 |
| 84484 | <1% | 30 | $194.85 | |
| 82550 | <1% | 44 | $180.16 | |
| 86769 | <1% | 32 | $180.00 | |
| 87807 | <1% | 13 | $167.52 | |
| 81003 | <1% | 67 | $96.66 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $94.00 |
| 83874 | <1% | 14 | $79.75 | |
| 86140 | <1% | 17 | $78.26 | |
| 82553 | <1% | 14 | $71.30 | |
| 85651 | <1% | 24 | $61.35 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANTHONY, SHELTON (CEO)